Orna Therapeutics - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeOrna Therapeutics
Orna Therapeutics logo

Orna Therapeutics

0 followers

About Orna Therapeutics

Orna Therapeutics is a biotechnology company engineering a new class of fully engineered circular RNA (oRNA) therapeutics to expand RNA medicine beyond traditional approaches. The company focuses on in vivo delivery using its LNP platform to reach sites throughout the body, with initial emphasis on oncology, autoimmune diseases, and infectious diseases, and is based in Watertown, Massachusetts. Orna aims to deliver first-in-class RNA drugs that can treat diseases without harsh preconditioning, leveraging its panCAR in vivo CAR technology and bone marrow targeting. The organization combines scientists, engineers, and seasoned leadership to bring oRNA therapeutics to patients globally.

Recent News

Recent Deals

Key Team Members

Joe Bolen, Ph.D.

Chief Executive Officer

Teresa Lipcsey, CPA, CGMA

Senior Vice President, Head of Finance & Accounting

Hope D’Oyley-Gay, JD

Chief Legal Officer

Frank Neumann, M.D., Ph.D.

Chief Medical Officer

Ciaran Lawlor, Ph.D.

Chief Operating Officer

Key Facts

HQ Location

Watertown, United States

Founded

2019

Employees

51 - 200

Status

Private

Website

https://ornatx.com